FR2963350B1 - Nouveaux copolymeres a bloc et leurs utilisations pour delivrer une substance active dans une cellule. - Google Patents

Nouveaux copolymeres a bloc et leurs utilisations pour delivrer une substance active dans une cellule.

Info

Publication number
FR2963350B1
FR2963350B1 FR1056334A FR1056334A FR2963350B1 FR 2963350 B1 FR2963350 B1 FR 2963350B1 FR 1056334 A FR1056334 A FR 1056334A FR 1056334 A FR1056334 A FR 1056334A FR 2963350 B1 FR2963350 B1 FR 2963350B1
Authority
FR
France
Prior art keywords
active substance
gen
copolymer
delivering
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1056334A
Other languages
English (en)
Other versions
FR2963350A1 (fr
Inventor
Herve Cheradame
Philippe Guegan
Basoly Rasolonjatovo
Mathieu Sassatelli
Bruno Pitard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D EVRY VAL D ESSONNE, University of
Universite D'Evry Val D'Essonne
Original Assignee
D EVRY VAL D ESSONNE, University of
Universite D'Evry Val D'Essonne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D EVRY VAL D ESSONNE, University of, Universite D'Evry Val D'Essonne filed Critical D EVRY VAL D ESSONNE, University of
Priority to FR1056334A priority Critical patent/FR2963350B1/fr
Publication of FR2963350A1 publication Critical patent/FR2963350A1/fr
Application granted granted Critical
Publication of FR2963350B1 publication Critical patent/FR2963350B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0233—Polyamines derived from (poly)oxazolines, (poly)oxazines or having pendant acyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/024—Polyamines containing oxygen in the form of ether bonds in the main chain
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/02—Polyamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1056334A 2010-07-30 2010-07-30 Nouveaux copolymeres a bloc et leurs utilisations pour delivrer une substance active dans une cellule. Active FR2963350B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1056334A FR2963350B1 (fr) 2010-07-30 2010-07-30 Nouveaux copolymeres a bloc et leurs utilisations pour delivrer une substance active dans une cellule.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1056334A FR2963350B1 (fr) 2010-07-30 2010-07-30 Nouveaux copolymeres a bloc et leurs utilisations pour delivrer une substance active dans une cellule.

Publications (2)

Publication Number Publication Date
FR2963350A1 FR2963350A1 (fr) 2012-02-03
FR2963350B1 true FR2963350B1 (fr) 2013-11-01

Family

ID=43640536

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1056334A Active FR2963350B1 (fr) 2010-07-30 2010-07-30 Nouveaux copolymeres a bloc et leurs utilisations pour delivrer une substance active dans une cellule.

Country Status (1)

Country Link
FR (1) FR2963350B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10278991B2 (en) 2014-05-14 2019-05-07 Targimmune Therapeutics Ag Polyethyleneimine polyethyleneglycol vectors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9000762A (nl) * 1990-03-31 1991-10-16 Stamicarbon Blokcopolymeren van tetrahydrofuran en oxazoline, hydrolyse producten hiervan en een werkwijze ter vervaardiging van deze blokcopolymeren.
US7665466B2 (en) * 2005-11-14 2010-02-23 Occlutech Gmbh Self-expanding medical occlusion device

Also Published As

Publication number Publication date
FR2963350A1 (fr) 2012-02-03

Similar Documents

Publication Publication Date Title
Das et al. Dextrin/poly (HEMA): pH responsive porous hydrogel for controlled release of ciprofloxacin
HRP20191852T1 (hr) Polipeptidi
AU2014218569B2 (en) Nanoparticles for controlled release of anti-biofilm agents
Kasza et al. Challenges and solutions in polymer drug delivery for bacterial biofilm treatment: a tissue-by-tissue account
CY1118661T1 (el) Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων
CY1119140T1 (el) Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους
Sreenivas et al. Thiolated chitosans: novel polymers for mucoadhesive drug delivery–a review
CY1120360T1 (el) Μεθοδος για την προωθηση της αγγειογενεσης, της αγγειωσης ή της αποκαταστασης των αγγειων, ή για την αναστολη της αγγειογενεσης ογκων
EP2537533A3 (fr) Bio-conjugués antitumoraux d'acide hyaluronique ou ses dérivés obtenus par une conjugaison chimique indirecte
MX2011005092A (es) Composicion de octenidina.
EA201070421A1 (ru) Микрорибонуклеиновые кислоты
JP2018502956A5 (fr)
UA112069C2 (uk) Біорозкладана композиція для доставки лікарських засобів (варіанти)
WO2016210376A3 (fr) Peptides thérapeutiques et leurs procédés d'utilisation
RU2013114400A (ru) Способ и композиция для лечения рака
Ko et al. Reductively-sheddable cationic nanocarriers for dual chemotherapy and gene therapy with enhanced release
CL2022000729A1 (es) Derivado de heteroarilamidopiridinol y composición farmacéutica que comprende el mismo como ingrediente activo para prevención o tratamiento de enfermedad autoinmune
Zhao et al. Microneedles: a novel strategy for wound management
Limqueco et al. Mannose conjugated polymer targeting P. aeruginosa biofilms
An et al. Fabrication of self‐healing hydrogel from quaternized N‐[3 (dimethylamino) propyl] methacrylamide copolymer for antimicrobial and drug release applications
Duarte et al. Multifunctional hydrogels-based therapies for chronic diabetic wound healing
FR2963350B1 (fr) Nouveaux copolymeres a bloc et leurs utilisations pour delivrer une substance active dans une cellule.
Jia et al. Dynamic microenvironment-adaptable hydrogel with photothermal performance and ROS scavenging for management of diabetic ulcer
Sabri et al. Fabrication and characterisation of poly (sulfonated) and poly (sulfonic acid) dissolving microneedles for delivery of antibiotic and antifungal agents
Li et al. Growth Factors-Loaded Temperature-Sensitive Hydrogel as Biomimetic Mucus Attenuated Murine Ulcerative Colitis via Repairing the Mucosal Barriers

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14